87 related articles for article (PubMed ID: 1605167)
21. Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
Romain S; Chinot O; Klijn JG; van Putten WL; Guirou O; Look M; Martin PM; Foekens JA
Br J Cancer; 1994 Aug; 70(2):304-8. PubMed ID: 8054279
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
Durocher Y; Chapdelaine A; Chevalier S
Cancer Res; 1989 Sep; 49(17):4818-23. PubMed ID: 2474374
[TBL] [Abstract][Full Text] [Related]
23. Solid-phase tyrosine-specific protein kinase assay in multiwell substrate-immobilized polyacrylamide gel.
Sahal D; Fujita-Yamaguchi Y
Anal Biochem; 1989 Oct; 182(1):37-43. PubMed ID: 2604046
[TBL] [Abstract][Full Text] [Related]
24. Detection of fms-oncogene-specific tyrosine kinase activity in human leukemia cells.
Tamura T; Brost H; Käbisch A; Lampert F; Hadwiger-Fangmeier A; Niemann H
J Cancer Res Clin Oncol; 1989; 115(3):235-41. PubMed ID: 2526817
[TBL] [Abstract][Full Text] [Related]
25. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
26. Selective effect of poly(lysine) on the enhancement of the lyn tyrosine protein kinase activity. Increased specificity toward src peptides.
Donella-Deana A; Marin O; Brunati AM; Pinna LA
Eur J Biochem; 1992 Mar; 204(3):1159-63. PubMed ID: 1372554
[TBL] [Abstract][Full Text] [Related]
27. The expression of carbonic anhydrase II in hematological malignancies.
Leppilampi M; Koistinen P; Savolainen ER; Hannuksela J; Parkkila AK; Niemelä O; Pastoreková S; Pastorek J; Waheed A; Sly WS; Parkkila S; Rajaniemi H
Clin Cancer Res; 2002 Jul; 8(7):2240-5. PubMed ID: 12114426
[TBL] [Abstract][Full Text] [Related]
28. The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia.
Tokumine Y; Waki K; Nishimori Y; Kuratsune H; Inoue R; Nakamura Y; Ueda E; Machii T; Kitani T
Leukemia; 1989 Jul; 3(7):516-21. PubMed ID: 2786598
[TBL] [Abstract][Full Text] [Related]
29. Identification of a 58,000 daltons phosphoprotein with tyrosine protein kinase activity in a murine lymphoma cell line.
Gacon G; Fagard R; Boissel JP; Fischer S; Reibel L; Piau JP; Schapira G; Comoglio PM
Biochem Biophys Res Commun; 1984 Jul; 122(2):563-70. PubMed ID: 6540563
[TBL] [Abstract][Full Text] [Related]
30. Mutated tyrosine kinases as therapeutic targets in myeloid leukemias.
Sattler M; Scheijen B; Weisberg E; Griffin JD
Adv Exp Med Biol; 2003; 532():121-40. PubMed ID: 12908554
[TBL] [Abstract][Full Text] [Related]
31. BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
Zaja F; Di Loreto C; Amoroso V; Salmaso F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Mariuzzi L; Beltrami CA; Baccarani M
Leuk Lymphoma; 1998 Feb; 28(5-6):567-72. PubMed ID: 9613987
[TBL] [Abstract][Full Text] [Related]
32. Stimulation by NaCl, polylysine and heparin of two forms of spleen tyrosine protein kinase immunologically related with the protein expressed by lyn oncogene.
Brunati AM; Donella-Deana A; Ralph S; Marchiori F; Borin G; Fischer S; Pinna LA
Biochim Biophys Acta; 1991 Jan; 1091(1):123-6. PubMed ID: 1995063
[TBL] [Abstract][Full Text] [Related]
33. Characterization of tyrosine protein kinase associated with subcellular components of human colonic epithelium.
Schwartz B; Cagnano E; Braun S; Lamprecht SA
Anticancer Res; 1990; 10(6):1747-53. PubMed ID: 2285253
[TBL] [Abstract][Full Text] [Related]
34. [Synthesis and biological activity of tyrosine protein kinase inhibitors].
Pang SH; Guo ZR; Liang XT
Yao Xue Xue Bao; 1997 Jul; 32(7):515-23. PubMed ID: 11596277
[TBL] [Abstract][Full Text] [Related]
35. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1.
Okuda K; Matulonis U; Salgia R; Kanakura Y; Druker B; Griffin JD
Exp Hematol; 1994 Oct; 22(11):1111-7. PubMed ID: 7925778
[TBL] [Abstract][Full Text] [Related]
36. Characterization of four tyrosine protein kinases from the particulate fraction of rat spleen.
Brunati AM; Pinna LA
Eur J Biochem; 1988 Mar; 172(2):451-7. PubMed ID: 3350007
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator inhibitor-2 in patients with monocytic leukemia.
Scherrer A; Kruithof EK; Grob JP
Leukemia; 1991 Jun; 5(6):479-86. PubMed ID: 2056772
[TBL] [Abstract][Full Text] [Related]
38. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
Chai SK; Nichols GL; Rothman P
J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
[TBL] [Abstract][Full Text] [Related]
39. [Alpha-L-fucosidase of normal and pathological blood cells].
Percheron F; Bernard M; Foglietti MJ
Bull Acad Natl Med; 1991 Feb; 175(2):205-14; discussion 215. PubMed ID: 1863862
[TBL] [Abstract][Full Text] [Related]
40. The spleen protein-tyrosine kinase TPK-IIB is highly similar to the catalytic domain of p72syk.
Brunati AM; James P; Guerra B; Ruzzene M; Donella-Deana A; Pinna LA
Eur J Biochem; 1996 Sep; 240(2):400-7. PubMed ID: 8841405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
